Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Nutr Cancer ; 67(7): 1142-50, 2015.
Article in English | MEDLINE | ID: mdl-26312410

ABSTRACT

The present study provides experimental evidence of in vivo reduction of genotoxic and mutagenic activities of potent carcinogen N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) by the strain Lactobacillus rhamnosus Vc. In vitro studies revealed that coincubation of MNNG with viable cells of L. rhamnosus Vc resulted in the detoxification of the parent compound accompanied with reduction in genotoxicity (69%) and mutagenicity (61%) as evaluated by SOS-Chromotest and Ames test, respectively. Oral feeding of probiotic bacteria L. rhamnosus Vc (10(9) cfu) to Gallus gallus (chicks) for 30 days provided protection against MNNG-induced damage as evidenced from the significant decrease (P = 0.009) in glutathione S-transferase activity in the L. rhamnosus Vc+MNNG-treated chicks in comparison to the MNNG-treated chicks. Histopathology of colon and liver showed intact cells and mild inflammation in the L. rhamnosus Vc+MNNG-treated chicks, whereas heavy inflammation and degenerative changes were observed in MNNG-treated chicks. The results indicate that the probiotic L. rhamnosus Vc provided in vivo protection against MNNG-induced colon damage by detoxification of MNNG to less toxic metabolites.


Subject(s)
Antimutagenic Agents/pharmacology , Lacticaseibacillus rhamnosus/metabolism , Methylnitronitrosoguanidine/toxicity , Probiotics/pharmacology , Animals , Body Weight/drug effects , Carcinogens/administration & dosage , Carcinogens/pharmacokinetics , Carcinogens/toxicity , Chickens , Colon/drug effects , Colon/pathology , Dose-Response Relationship, Drug , Glutathione Transferase/metabolism , Hydrogen-Ion Concentration , Inactivation, Metabolic , Lacticaseibacillus rhamnosus/drug effects , Liver/drug effects , Liver/pathology , Male , Methylnitronitrosoguanidine/administration & dosage , Methylnitronitrosoguanidine/pharmacokinetics , Mutagenicity Tests/methods , Spleen/drug effects , Spleen/pathology
2.
J Bacteriol ; 190(15): 5210-6, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18502851

ABSTRACT

The genome of the halophilic archaeon Halobacterium sp. strain NRC-1 encodes homologs of the eukaryotic Mre11 and Rad50 proteins, which are involved in the recognition and end processing of DNA double-strand breaks in the homologous recombination repair pathway. We have analyzed the phenotype of Halobacterium deletion mutants lacking mre11 and/or rad50 after exposure to UV-C radiation, an alkylating agent (N-methyl-N'-nitro-N-nitrosoguanidine), and gamma radiation, none of which resulted in a decrease in survival of the mutant strains compared to that of the background strain. However, a decreased rate of repair of DNA double-strand breaks in strains lacking the mre11 gene was observed using pulsed-field gel electrophoresis. These observations led to the hypothesis that Mre11 is essential for the repair of DNA double-strand breaks in Halobacterium, whereas Rad50 is dispensable. This is the first identification of a Rad50-independent function for the Mre11 protein, and it represents a shift in the Archaea away from the eukaryotic model of homologous recombination repair of DNA double-strand breaks.


Subject(s)
Archaeal Proteins/genetics , Archaeal Proteins/metabolism , DNA Breaks, Double-Stranded , DNA Repair , Endodeoxyribonucleases/genetics , Endodeoxyribonucleases/metabolism , Exodeoxyribonucleases/genetics , Exodeoxyribonucleases/metabolism , Halobacterium/physiology , Alkylating Agents/pharmacology , DNA, Archaeal/chemistry , Electrophoresis, Gel, Pulsed-Field , Gamma Rays , Gene Deletion , Halobacterium/drug effects , Halobacterium/enzymology , Halobacterium/radiation effects , Methylnitronitrosoguanidine/pharmacokinetics , Microbial Viability , Ultraviolet Rays
3.
Mutat Res ; 523-524: 43-53, 2003.
Article in English | MEDLINE | ID: mdl-12628502

ABSTRACT

Doenjang (Korean fermented soypaste) is one of the important fermented foods of Korea. Doenjang has been traditionally manufactured from meju, which is fermented rectangular shape molded from crushed cooked soybeans. The main microorganisms involved for meju fermentation are Bacillus subtilis and molds such as Rizopus sp., Mucor sp., and Aspergillus sp. We have already reported that doenjang is safe from mycotoxin, especially, aflatoxin contamination due to the manufacturing process of the doenjang. We have demonstrated that the doenjang extracts showed strong antimutagenic activities against various carcinogens/mutagens including aflatoxin B(1). The traditionally fermented soypaste, doenjang showed higher antimutagenic activity than the raw soybeans, cooked soybeans, meju and other fermented soybeans in the Ames test. The active compounds that were identified are genistein, linoleic acid, beta-sitosterol glucoside, soyasaponin, etc. The active compounds exhibited strong antimutagenic activities in the Ames test, SOS chromotest and Drosophila wing spot test. More genistein was formed during the doenjang fermentation from genistin in the soybeans. Genistein and linoleic acid were the most effective active compounds found in doenjang.


Subject(s)
Aflatoxins/pharmacokinetics , Antimutagenic Agents/pharmacology , Fungi/metabolism , Glycine max/chemistry , Glycine max/microbiology , Mutagens/pharmacokinetics , 4-Nitroquinoline-1-oxide/pharmacokinetics , Aflatoxin B1/pharmacokinetics , Antimutagenic Agents/chemistry , Benzo(a)pyrene/pharmacokinetics , Biodegradation, Environmental , Fermentation , Fungi/isolation & purification , Korea , Linoleic Acid/pharmacology , Methylnitronitrosoguanidine/pharmacokinetics , Quinolones/pharmacokinetics
4.
Dig Dis Sci ; 47(10): 2354-69, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12395909

ABSTRACT

The mucosal changes by which duodenogastric reflux may predispose to gastric cancer have not been fully clarified. In this study in rats, duodenal fluid was directed into the stomach through a gastroenterostomy (jejunal reflux, N = 29) or through the pylorus (pyloric reflux, N = 30) and compared with 30 controls. Twenty-four weeks later the stomach was exposed to N-[3H]methyl-N-nitro-N-nitrosoguanidine ([3H]MNNG). The corpus mucosa was examined for proliferating cells (bromodeoxyuridine labeled) and cells at risk of methyl-N-nitro-N-nitrosoguanidine-induced carcinogenesis (cells labeled with bromodeoxyuridine and [3H]MNNG). The number of double-labeled cells increased from 0.8 +/- 0.1/mm mucosa in the control group to 5.2 +/- 0.9 in the jejunal reflux group (P < 0.05) and 2.7 +/- 0.5 in the pyloric reflux group (P < 0.05). An erosion or ulcer appeared at the gastroenterostomy in 52% of animals with jejunal reflux and 17% of those with pyloric reflux (P < 0.006). Within erosions the mean number of double-labeled cells was 9.6 +/- 2.2 in the jejunal reflux group and 7.7 +/- 4.8 in the pyloric reflux group, and significantly higher than in the nonlesion area of the mucosa (0.6 +/- 0.2 and 0.8 +/- 0.3). In erosions the distance between the gastric lumen and the proliferating cells was significantly shorter and the cell proliferation significantly higher than in the nonlesion area of the mucosa. We conclude that duodenogastric reflux increases the penetration of [3H]MNNG into the corpus mucosa of rats and also induces mucosa lesions, which further increase the penetration of [3H]MNNG into the corpus mucosa.


Subject(s)
Duodenogastric Reflux/pathology , Gastric Mucosa/pathology , Methylnitronitrosoguanidine/pharmacokinetics , Animals , Cell Transformation, Neoplastic/pathology , Male , Methylnitronitrosoguanidine/toxicity , Rats , Rats, Wistar , Stomach Neoplasms/chemically induced , Stomach Neoplasms/pathology , Tritium
5.
Dig Dis Sci ; 44(10): 2063-75, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10548359

ABSTRACT

Glutathione plays a role in gastric mucosal protection and the glutathione level is elevated in some forms of gastritis. We studied the relevance of glutathione for the penetration of N-methyl-N-nitro-N-nitrosoguanidine in the glandular mucosa of the stomach. Male Wistar rats were treated with glutathione (0.5 mmol/kg intravenously), N-acetylcysteine (0.5 mmol/kg intravenously), or L-buthionine-[S,R,]-sulfoximine (BSO, 2 mmol/kg intraperitoneally), before the gastric mucosa was exposed to N-[3H]methyl-N-nitro-N-nitrosoguanidine for 10 min. Penetration of the carcinogen was evaluated by light microscopic identification of cells labeled with bromodeoxyuridine and N-[3H]methyl-N-nitro-N-nitrosoguanidine (double-labeled cells). Thiol substances were quantified by reversed-phase ion-pair liquid chromatography and fluorescence detection. The percentage double-labeled cells was higher in antrum mucosa (11.7 +/- 3.1%) than in corpus mucosa (1.1 +/- 0.2%) (P < 0.05). Total glutathione level was 1853 +/- 101 nmol/g in antrum and 1560 +/- 76 nmol/g in corpus mucosa. BSO administration reduced the amount of glutathione in antrum to 495 +/- 14 nmol/g (P < 0.05) and reduced the percentage double-labeled cells in antrum mucosa to 6.1 +/- 1.3% (P < 0.05). A positive correlation was found between the percentage of double-labeled cells in the antrum mucosa and the total amount of glutathione (r = 0.451, P = 0.002), and the amount of reduced glutathione (r = 0.449, P = 0.002). Glutathione modulation effects the penetration of N-[3H]methyl-N-nitro-N-nitrosoguanidine in the antrum but not in the corpus mucosa. Thiols do not explain the different penetration of carcinogen in antrum and corpus mucosa.


Subject(s)
Carcinogens/pharmacokinetics , Gastric Mucosa/drug effects , Glutathione/physiology , Methylnitronitrosoguanidine/pharmacokinetics , Animals , Carcinogens/toxicity , Cysteine/metabolism , Dipeptides/metabolism , Gastric Mucosa/metabolism , Glutathione/pharmacology , Homocysteine/metabolism , Male , Methylnitronitrosoguanidine/toxicity , Rats , Rats, Wistar
6.
Article in English | MEDLINE | ID: mdl-9256928

ABSTRACT

The aromatic amine 2-aminofluorene (2-AF) was activated by the intact Chlamydomonas reinhardtii cells to a mutagen that exhibited toxic and mutagenic effects comparable to those of the direct-acting mutagen N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). There were different responses of the wildtype and repair-deficient strains to the toxic and mutagenic effect of 2-AF. The recombination repair plays a major role in repair of damages induced in the C. reinhardtii DNA by the aromatic amine promutagen 2-AF and the direct-acting mutagen MNNG. The 2-AF activation has also been analyzed by algal cells/microbe coincubation assay. This new assay is used in addition to animal microsome-metabolizing system (S9 fraction) and plant cell/microbe coincubation assay. This additional system is suitable for detection of environmental promutagens and their conversion to mutagens, mainly in aquatic environments.


Subject(s)
Chlamydomonas reinhardtii/genetics , Fluorenes/pharmacokinetics , Mutagens/pharmacokinetics , Prodrugs/pharmacokinetics , Animals , Biotransformation/genetics , Chlamydomonas reinhardtii/metabolism , Coculture Techniques , Methylnitronitrosoguanidine/pharmacokinetics , Mutagenicity Tests , Salmonella typhimurium/genetics , Salmonella typhimurium/metabolism
7.
Dig Dis Sci ; 40(12): 2509-15, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8536504

ABSTRACT

The effects of intragastric capsaicin and gastric artery ligation on the penetration of the gastric carcinogen N[methyl-3H]-N'-nitro-N-nitrosoguanidine ([3H]MNNG) to proliferative cells were studied in normal and healing rat gastric mucosa. The percentage of S-phase cells labeled with [3H]MNNG in normal corpus mucosa was higher (7.0 +/- 2.0%) after gastric artery ligation than in controls with intact blood flow (2.7 +/- 1.0%) and in animals treated with capsaicin (1.8 +/- 0.5%). Corpus mucosal blood flow was correlated with the percentage of S-phase cells labeled with [3H] MNNG in normal controls and in capsaicin-treated animals. In healing corpus mucosa and in the antrum, capsaicin or gastric artery ligation did not affect carcinogen penetration. We conclude that blood flow protects against penetration of carcinogens to proliferative cells in normal corpus mucosa but not in the antrum. Low mucosal blood flow in the corpus could be a risk factor for initiation of gastric carcinogenesis.


Subject(s)
Carcinogens/pharmacology , Gastric Mucosa/blood supply , Methylnitronitrosoguanidine/pharmacology , Stomach Neoplasms/chemically induced , Animals , Arteries/surgery , Capsaicin/pharmacology , Carcinogens/pharmacokinetics , Cell Division/drug effects , Gastric Mucosa/cytology , Ligation , Male , Methylnitronitrosoguanidine/pharmacokinetics , Pyloric Antrum/blood supply , Rats , Rats, Wistar , Regional Blood Flow/physiology , Risk Factors , S Phase , Stomach/blood supply , Tritium
9.
Dig Dis Sci ; 40(8): 1720-8, 1995 Aug.
Article in English | MEDLINE | ID: mdl-7648971

ABSTRACT

In this study we tested the influence of blood flow and the mucoid cap on the penetration of carcinogens to the proliferative cells in the injures rat gastric mucosa. Ten minutes after mucosal exposure to 4.5 mol/liter NaCl, N-[3H]methyl-N'-nitro-N-nitrosoguanidine was instilled intragastrically. Hypertonic saline caused superficial mucosal damage, formation of a mucoid cap, high gastric mucosal blood flow, and a large flux of fluid into the gastric lumen. The mean percentage of S-phase cells labeled with carcinogen (the cell population at risk for N-methyl-N'nitro-N-nitrosoguanidine-induced carcinogenesis) in the antrum and corpus was 0.2 and 0.2, respectively, in the injury control group, 10.1 and 2.0 after removal of the mucoid cap, 1.5 and 9.8 after celiac artery ligation, and 28.2 and 21.9 after removal of the mucoid cap and celiac artery ligation. These results show that both the mucoid cap and gastric mucosal blood flow protect against penetration of carcinogens into the superficially injured gastric mucosa.


Subject(s)
Gastric Mucosa/blood supply , Methylnitronitrosoguanidine/pharmacokinetics , Mucus/physiology , Animals , Celiac Artery , Gastric Mucosa/metabolism , Gastric Mucosa/pathology , Ligation , Male , Rats , Rats, Wistar , Regional Blood Flow , Stomach Neoplasms/chemically induced , Stomach Neoplasms/physiopathology
10.
J Clin Gastroenterol ; 12 Suppl 1: S116-24, 1990.
Article in English | MEDLINE | ID: mdl-2212537

ABSTRACT

In prostaglandin E2 (PGE2)-, pirenzepine-, and indomethacin-administered rats, the incorporation of N-[methyl-3H]-N'-nitro-N-nitrosoguanidine ([methyl-3H]MNNG) into gastric mucosal DNA was measured quantitatively by liquid scintillation counting after intragastric instillation of [methyl-3H]MNNG. The amount of incorporation was 25.4 +/- 5.9 pmol/mg DNA in control rats, 11.7 +/- 3.8 pmol/mg DNA in PGE2-administered rats, 6.2 +/- 5.6 pmol/mg DNA in pirenzepine-administered rats, and 42.9 +/- 14.4 pmol/mg DNA in indomethacin-administered rats. PGE2 and pirenzepine significantly decreased the incorporation as compared with the control group. In contrast, indomethacin increased the incorporation. In addition, gastric mucosa of these drug-treated rats was studied histochemically. PGE2 and pirenzepine increased secretion of gastric mucus whereas indomethacin decreased it. It is possible that gastric mucus has a protective effect not only against ulcerogenic agents but also against carcinogens. It is considered that gastric mucus plays an important role in the defense mechanism against carcinogenesis.


Subject(s)
DNA/metabolism , Gastric Mucosa/metabolism , Methylnitronitrosoguanidine/pharmacokinetics , Mucus/physiology , Animals , Dinoprostone/pharmacology , Gastric Mucosa/drug effects , Indomethacin/pharmacology , Male , Mucus/drug effects , Pirenzepine/pharmacology , Rats , Rats, Inbred Strains , Stomach Neoplasms/chemically induced , Stomach Neoplasms/prevention & control
11.
Chem Res Toxicol ; 2(3): 157-61, 1989.
Article in English | MEDLINE | ID: mdl-2535270

ABSTRACT

The cytotoxic activity of N-methyl-N-nitrosourea (MNU), streptozotocin, and N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) was determined in cell culture by using a P388 cell growth rate inhibition assay. These agents appear to have very different activities when inhibition is related to the agent concentration in the culture medium: ED50(C0) = 40 microM for MNNG to 875 microM for streptozotocin. The mechanism of action of these three agents involves conversion to the active methanediazonium ion and subsequent methylation of cellular macromolecules. As a consequence, the rates of conversion of the parent agent to the methylating species in the medium and within the cell are important parameters that also need to be considered to reach a more detailed understanding of the mechanism of action. In order to do this, a kinetic model has been developed to calculate the concentration of drug that is converted to active methylating species within the cell during the assay incubation period. The use of cell culture kinetic models was extended from simple compounds activated through solvolytic reactions (nitrosoureas) to an agent that undergoes selective intracellular activation (MNNG). By use of measured values for initial drug concentration, incubation time, and cell volume, as well as extracellular and intracellular chemical activation rate constants, the intracellular concentration, [P4], which represents the cumulative intracellular reaction products formed during the incubation period, was calculated and related to cytotoxicity. All three agents showed an ED50[P4] between 140 and 180 microM, and for MNNG, this ED50 was independent of extracellular sulfhydryl concentration.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Methylnitronitrosoguanidine/pharmacology , Methylnitrosourea/pharmacology , Animals , Biotransformation , Cell Survival/drug effects , Leukemia P388/metabolism , Leukemia P388/pathology , Methylation , Methylnitronitrosoguanidine/pharmacokinetics , Methylnitrosourea/pharmacokinetics , Mice , Models, Biological , Streptozocin/pharmacokinetics , Streptozocin/pharmacology , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/metabolism , Tumor Cells, Cultured/pathology
12.
Proc Soc Exp Biol Med ; 188(2): 206-11, 1988 Jun.
Article in English | MEDLINE | ID: mdl-3375266

ABSTRACT

We studied the characteristics and mechanisms of MNNG (N-methyl-N'-nitro-N-nitrosoguanidine) intestinal absorption and the interaction between bile acids and fatty acids and MNNG absorption rate in vivo in male Sprague-Dawley rats. We perfused a segment of the proximal small bowel with a physiological solution containing MNNG to assess its basic kinetics and the influence of some physiological and dietary factors on carcinogen absorption. We found that MNNG was absorbed by simple passive diffusion. Transport of MNNG was the highest at pH 6.0. The addition of the bile salt, taurocholate by itself, greatly increased MNNG absorption, while the addition of the long-chain unsaturated fatty acids, oleic and linoleic, decreased the rate of absorption of MNNG. The phospholipid lecithin addition to the perfusate did not change the rate of MNNG absorption. Induction of dietary vitamin A deficiency (serum vitamin A level decreased from 40.9 to 13.7 micrograms/dl) did not change the absorption rate of MNNG. These studies demonstrate that bile acids, dietary fatty acids, and the pH of the intestinal content can modify the rate of absorption of this carcinogen by the small intestine. Since initial intestinal absorption determines serum levels and subsequent reabsorption and enterohepatic cycling determines long-term lumenal levels, serum levels, and total body content, factors which modify the rate of intestinal absorption of MNNG could also modify its carcinogenicity.


Subject(s)
Intestinal Absorption , Methylnitronitrosoguanidine/pharmacokinetics , Animals , Bile Acids and Salts/pharmacology , Cell Membrane/metabolism , Diffusion , Fatty Acids/pharmacology , Fatty Acids, Unsaturated/pharmacology , Hydrogen-Ion Concentration , Intestinal Absorption/drug effects , Male , Methylnitronitrosoguanidine/administration & dosage , Neoplasms, Experimental/chemically induced , Rats , Rats, Inbred Strains , Taurocholic Acid/pharmacology , Vitamin A Deficiency/metabolism
13.
Carcinogenesis ; 1(7): 567-75, 1980 Jul.
Article in English | MEDLINE | ID: mdl-11219831

ABSTRACT

1-Methyl-1-nitrosourea (MNU) and 1-methyl-3-nitro-1-nitrosoguanidine (MNNG) are carcinogens which methylate nucleic acids and proteins and covalently modify proteins by carbamoylation (MNU) or guanidination (MNNG). Using MNU and MNNG labeled with carbon-14 in the individual carbon positions, the above reactions were quantitated in the isolated guinea pig pancreas, an organ susceptible to tumorigenesis by MNU. Freshly prepared pancreatic lobules were incubated with the labeled drugs (0.03, 0.3 and 1.0 mM) for one hour at 37 degrees C. Alkylated purines from hydrolyzed DNA were separated on Sephadex G10 and acid-soluble nuclear proteins were extracted and separated on polyacrylamide gels. Total uptake of all four labels into lobules was linear with concentration. Acid insoluble radioactivity also increased linearly except for MNNG methylation which plateaued between 0.3 and 1.0 mM. 7-Methylguanine formation by both compounds was approximately ten fold greater than 06-methylation. However, DNA modification by MNU exceeded that by MNNG, especially at the higher drug concentrations. No carbamoylation or guanidination of DNA was detected. Total binding (methylation plus carbamoylation/guanidination) to acid-extractable chromatin proteins was equivalent to DNA modification on a molar basis (approximately 0.35 and 0.08 pmol/microg for exposure to 1.0 mM MNU and MNNG, respectively). All histones were labeled by all drug preparations, with H2A being the principal site of methylation and H2B, H3 and H1 being the major targets of carbamoylation and guanidination. H4 was the least modified histone. Drug binding to cytoplasmic organelles also occurred. These results show a broad spectrum of nuclear and cytoplasmic modification of pancreatic cells by MNU and, to a smaller extent, MNNG.


Subject(s)
Carcinogens/metabolism , Methylnitronitrosoguanidine/metabolism , Methylnitrosourea/metabolism , Pancreas/metabolism , Animals , Carbon Radioisotopes , Carcinogens/pharmacokinetics , Chemical Precipitation , Culture Techniques , DNA/drug effects , DNA/metabolism , DNA Methylation/drug effects , Female , Guinea Pigs , Histones/metabolism , Methylnitronitrosoguanidine/pharmacokinetics , Methylnitrosourea/pharmacokinetics , Nuclear Proteins/metabolism , Protein Binding , Subcellular Fractions/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...